BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24246275)

  • 1. Long-term swallow function after chemoradiotherapy for oropharyngeal cancer: the influence of a prophylactic gastrostomy or reactive nasogastric tube.
    Prestwich RJ; Teo MT; Gilbert A; Williams G; Dyker KE; Sen M
    Clin Oncol (R Coll Radiol); 2014 Feb; 26(2):103-9. PubMed ID: 24246275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of choice of feeding tubes on long-term swallow function following chemoradiotherapy for oropharyngeal carcinoma.
    Prestwich RJD; Murray LJ; Williams GF; Tease E; Taylor L; George C; Cardale K; Dyker KE; Murray P; Sen M; Ramasamy S
    Acta Oncol; 2019 Aug; 58(8):1187-1196. PubMed ID: 31032694
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of prophylactic gastrostomy or reactive NG tube upon patient-reported long term swallow function following chemoradiotherapy for oropharyngeal carcinoma: A matched pair analysis.
    Sethugavalar B; Teo MT; Buchan C; Ermiş E; Williams GF; Sen M; Prestwich RJD
    Oral Oncol; 2016 Aug; 59():80-85. PubMed ID: 27424186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Swallowing outcomes for patients with oropharyngeal squamous cell carcinoma treated with primary (chemo)radiation therapy receiving either prophylactic gastrostomy or reactive nasogastric tube: A prospective cohort study.
    Goff D; Coward S; Fitzgerald A; Paleri V; Moor JW; Patterson JM
    Clin Otolaryngol; 2017 Dec; 42(6):1135-1140. PubMed ID: 28128886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
    Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D
    Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: a role for a prophylactic gastrostomy?
    Williams GF; Teo MT; Sen M; Dyker KE; Coyle C; Prestwich RJ
    Oral Oncol; 2012 May; 48(5):434-40. PubMed ID: 22209648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
    Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS
    Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Patient-reported Swallow Function in the Long Term After Chemoradiotherapy for Oropharyngeal Carcinoma.
    Martin A; Murray L; Sethugavalar B; Buchan C; Williams GF; Sen M; Prestwich RJD
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):756-763. PubMed ID: 30025978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrostomy vs nasogastric tube feeding in patients with head and neck cancer during radiotherapy alone or combined chemoradiotherapy.
    Soria A; Santacruz E; Vega-Piñeiro B; Gión M; Molina J; Villamayor M; Mateo R; Riveiro J; Nattero L; Botella-Carretero JI
    Nutr Hosp; 2017 Jun; 34(3):512-516. PubMed ID: 28627183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Nutritional and Clinical Outcomes in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy Utilizing Prophylactic versus Reactive Nutrition Support Approaches.
    Brown TE; Banks MD; Hughes BGM; Lin CY; Kenny LM; Bauer JD
    J Acad Nutr Diet; 2018 Apr; 118(4):627-636. PubMed ID: 27986517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of enteral feeding route on patient-reported long term swallowing outcome after chemoradiation for head and neck cancer.
    Oozeer NB; Corsar K; Glore RJ; Penney S; Patterson J; Paleri V
    Oral Oncol; 2011 Oct; 47(10):980-3. PubMed ID: 21856212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrostomy versus nasogastric tube feeding for chemoradiation patients with head and neck cancer: the TUBE pilot RCT.
    Paleri V; Patterson J; Rousseau N; Moloney E; Craig D; Tzelis D; Wilkinson N; Franks J; Hynes AM; Heaven B; Hamilton D; Guerrero-Urbano T; Donnelly R; Barclay S; Rapley T; Stocken D
    Health Technol Assess; 2018 Apr; 22(16):1-144. PubMed ID: 29650060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteral feeding in head and neck cancer patients at a UK cancer centre.
    Sheth CH; Sharp S; Walters ER
    J Hum Nutr Diet; 2013 Oct; 26(5):421-8. PubMed ID: 23379517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrostomy Utilization by Oropharyngeal Cancer Patients Is Partially Driven by Swallowing Function.
    Chhabria K; Kansara S; Badr H; Stach C; Vernese M; Lerner A; Harms A; Hernandez DJ; Huang AT; Chen G; Parke RB; Charnitsky S; Sandulache VC
    Laryngoscope; 2020 Sep; 130(9):2153-2159. PubMed ID: 31566749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study.
    Dragan T; Van Gossum A; Duprez F; Lalami Y; Lefebvre Y; Mootassim-Billah S; Beauvois S; Gulyban A; Vandekerkhove C; Boegner P; Paesmans M; Ameye L; Digonnet A; Quiriny M; Dequanter D; Lipski S; Willemse E; Rodriguez A; Carlot S; Karaca Y; Lemort M; Emonts P; Al Wardi C; Van Gestel D
    Trials; 2022 Dec; 23(1):1036. PubMed ID: 36539781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal cancer.
    Strom T; Trotti AM; Kish J; Rao NG; McCaffrey J; Padhya TA; Lin HY; Fulp W; Caudell JJ
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1242-6. PubMed ID: 24136493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.
    Setton J; Lee NY; Riaz N; Huang SH; Waldron J; O'Sullivan B; Zhang Z; Shi W; Rosenthal DI; Hutcheson KA; Garden AS
    Cancer; 2015 Jan; 121(2):294-301. PubMed ID: 25286832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy.
    Nugent B; Lewis S; O'Sullivan JM
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD007904. PubMed ID: 23440820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional swallowing outcomes following transoral robotic surgery vs primary chemoradiotherapy in patients with advanced-stage oropharynx and supraglottis cancers.
    More YI; Tsue TT; Girod DA; Harbison J; Sykes KJ; Williams C; Shnayder Y
    JAMA Otolaryngol Head Neck Surg; 2013 Jan; 139(1):43-8. PubMed ID: 23247974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: A clinical prediction model-based approach.
    Karsten RT; Stuiver MM; van der Molen L; Navran A; de Boer JP; Hilgers FJM; Klop WMC; Smeele LE
    Oral Oncol; 2019 Jan; 88():172-179. PubMed ID: 30616790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.